Prenetics
Company

Last deal

$120M

Amount

Post-IPO Equity

Stage

18.05.2022

Date

3

all rounds

$187.65M

Total amount

date founded

Financing round

General

About Company
Prenetics is a genetic and diagnostic health testing company that identifies health risks using DNA sequencing technology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Prenetics provides individuals with valuable health information through a digital coaching app and a simple saliva sample. The app offers a DNA profile that helps people adjust their diet based on how their genes affect their diet, drug response, disease, and cancer risk. Prenetics operates its direct to consumer genomics business via its two brands, CircleDNA in Asia and DNAFit. The company is headquartered in Hong Kong and is listed on NASDAQ with the ticker PRE. Prenetics is dedicated to transforming patient care through advanced genomic and molecular technologies, with a focus on precision oncology. The recent acquisition of ACT Genomics has enabled Prenetics to expand its capabilities and offer comprehensive cancer solutions to patients worldwide.
Contacts

Contact Email

Phone number

Social url

Sub-Organizations
1
Circle DNA

Circle DNA

Circle aims to personalize prevention and eliminate late cancer and disease detection.

Sector

Medical Equipment and Services

Subsector

Medical Supplies

Location

Causeway Bay, Hong Kong
Similar Companies
1000
CircaGene

CircaGene

CircaGene is a company that offers personal genetic tests with total privacy and actionable results for preventive healthcare.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Biotechnology, Genetics

Location

London, UK

total rounds

2

total raised

$230.03K
Kailos Genetics

Kailos Genetics

Kailos Genetics offers personalized health information through clinical genetic assays and next-generation sequencing.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Huntsville, AL, USA

total rounds

2

total raised

$1.9M
Antegenes

Antegenes

Antegenes is a digital health company that uses advanced genetic tests to personalize cancer prevention and other complex diseases.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Tartu, Estonia

total rounds

4

total raised

$3.22M
Veritas Genetics

Veritas Genetics

Veritas Genetics is a global pioneer in consumer genetics and whole genome sequencing.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Biotechnology, Genetics

Location

Danvers, MA 01923, USA

total rounds

6

total raised

$61.44M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$187.65M

Money Raised

Their latest funding was raised on 18.05.2022. Their latest investor Aspex Management. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
18.05.2022
5
$120M
04.05.2021
1
Apis Partners

Apis Partners

Apis Partners is a private equity asset manager focused on financial services in growth markets.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

London, UK

count Of Investments

32

count Of Exists

5
Co-Investors
Investors
17
7

Number of lead investors

17

Number of investors

Investor 
Lead 
Round 
Partners 
No
Post-IPO Equity
No
Post-IPO Equity
No
Post-IPO Equity
Aspex Management

Aspex Management

Aspex Management is a Hong Kong-based investment manager founded in 2018.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Finance, Venture Capital

Location

Hong Kong Island, Hong Kong

count Of Investments

17
Xen Capital

Xen Capital

Xen Capital is a fintech platform that allows accredited investors in Asia to access and trade alternative investments.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Singapore

total rounds

2

total raised

$9.3M

count Of Investments

1
PAG

PAG

PAG is a leading alternative investment firm in the APAC region, managing capital for institutional fund investors.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Real Estate Investment

Location

Tokyo, Japan

total rounds

1

count Of Investments

33

count Of Exists

2
Acquisitions
3
Acquiree Name 
Date 
Price 
Acquisition Name 
ACT Genomics acquired by Prenetics

ACT Genomics acquired by Prenetics

acquirer

Prenetics
Prenetics

date

16.12.2022

type

Acquisition
ACT Genomics

ACT Genomics

ACT Genomics transforms cancer genomic information into precision diagnosis and personalized treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Taipei City, Taiwan

total rounds

5

total raised

$20.5M
SOMA Analytics acquired by Prenetics

SOMA Analytics acquired by Prenetics

acquirer

Prenetics
Prenetics

date

29.01.2019

type

Acquisition
SOMA Analytics

SOMA Analytics

Soma Analytics is developing mobile health technology that combines psychology, medicine, machine learning and hardware.

Sector

Health Care Providers

Subsector

Health Care Services

Location

London, UK

total rounds

5

total raised

$2.22M
DNAFit acquired by Prenetics

DNAFit acquired by Prenetics

acquirer

Prenetics
Prenetics

date

17.04.2018

type

Acquisition

price

$10M
DNAFit

DNAFit

DNAFit provides genetic testing services that help people understand how their DNA affects their response to exercise and nutrition changes.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Fitness, Biotechnology

Location

London, UK

People

Founders
3
Lawrence Tzang
Lawrence Tzang

Lawrence Tzang

Dr. Tzang, Co-Founder, and serves as Chief Scientific Officer, is recognized as a pioneer in DNA chip-based Molecular Diagnostic Techniques. He has over 15 years of industry experience and has spearheaded the development of over 30 proprietary panels, including DNA Microarray and Microfluidic platforms focused on female health and prenatal diagnostics which has been used in research and in clinical settings. Dr. Tzang is also a Founding Member of Hong Kong Society for Behavioural and Neural Genetics. Dr. Tzang holds seven global patents/patent applications and has authored 30 scientific articles. Dr. Tzang received his Ph.D in Molecular Biology from City University of Hong Kong.

current job

Prenetics
Prenetics

organization founded

2

Lawrence Tzang

Danny Yeung
Danny Yeung

Danny Yeung

Danny Yeung serves as Chief Executive Officer and sets the business strategies along with the vision for Prenetics. Prior to joining Prenetics, Danny as Founding Partner/Investor at SXE Ventures led multiple investments in DNA Genetic testing companies. Previously, Danny had founded uBuyiBuy in 2010 which was subsequently acquired by Groupon. Prior to Danny leaving Groupon in early 2014, Danny served as CEO of Groupon East Asia, having scaled the business to a size of over USD $130m annually, overseeing a staff of 350 and being highly profitable. Danny’s entrepreneurial journey started at the age of 25 when he ventured into franchising Hong Kong award-winning dessert chain Hui Lau Shan into USA. After exiting Hui Lau Shan, Danny successfully ventured into hospitality furniture and executed multi-million dollar projects with MGM City Center, City of Dreams Macau and Venetian Danny is currently a Founding Partner at SXE Ventures, Board Member at Parabase Genomics, Limited Partner and Mentor for 500 Startups. Danny received his BS in MIS from the University of San Francisco.

current job

Fave
Fave

count Of Investments

5

count Of Exists

1

Danny Yeung

Michael M. Yang
Michael M. Yang

Michael M. Yang

Professor Yang is a co-founder of Prenetics (formerly named Multigene) as a spin-off from City University focusing on the development of molecular diagnostics for early detection of diseases.Professor Yang’s research interest focuses on the development of biochip technology and nanomedicine for basic research and clinical applications. Professor Yang has published over 200 peer-reviewed scientific papers and obtained 23 patents. He has delivered more than 160 invited lectures in international conferences and universities, and trained 24 PhD/M.Phil. students and numerous postdoctoral fellows in his laboratory. He holds honorary professorships in Zhejiang University and the Third Military Medical University. Professor Yang serves in the grant review boards of Hong Kong Government Health and Medical Research Fund and Innovation and Technology Fund. He has been awarded the Chunhui Scholar Award by the Ministry of Education in China in 2003, the K. C. Wong Foundation Award in 2004, the Shenzhen Science and Technology Innovation Award in 2006, and the Hong Kong Technological Achievement Grand Award in 2007. Professor Yang obtained his PhD from University of Toronto and postdoctoral training in the Scripps Research Institute in USA.

current job

Prenetics
Prenetics

organization founded

1

Michael M. Yang

Employee Profiles
15
Avi Lasarow

Avi Lasarow

CEO Europe, Middle East & Africa

Kimmy Tam

People and culture manager

Stephen Lo

Stephen Lo

CFO

Peter Wong

Peter Wong

CTO

Stephen Leung

User interface and user experience designer

Senthil Sundaram

Senthil Sundaram

Chief Clinical Officer

Jennifer Aum

Commercial advisor, previously vice president of growth

Danny Yeung

Danny Yeung

CEO / Co-Founder

Activity

Recent News
1